Chicago, IL – July 14, 2010 - Panthera Global, Inc. (“PGI”) is pleased to announce that it has been retained by a developer of organ preservation and transport systems (the “Company”) to raise up to $6 million of equity growth capital.  The capital raise will fund the engineering and manufacturing of the device, IP filings on the commercial designs, clinical testing, FDA approval, regulatory filings and the commercial launch of a kidney preservation device.

The Company has devised a design & engineering plan that will produce a ready-to-market product by Q1 2011.  The Company expects to apply for regulatory approval of this ready-to-market product by Q4 2011.  By 2013 and 2014, the Company expects to launch a heart device and liver device, respectively.